Imperial College London


Faculty of MedicineDepartment of Medicine

Wynn Chair in Human Metabolism (Clinical)



+44 (0)20 3313 1593nick.oliver




7S7aCommonwealth BuildingHammersmith Campus





Nick is the Wynn professor of human metabolism and is a consultant diabetes and endocrinology Imperial College Healthcare NHS Trust. His clinical and academic interest is type 1 diabetes and the application of technology.



Ramli R, Reddy M, Oliver N, 2019, Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes., Drugs

Agha-Jaffar R, Oliver NS, Kostoula M, et al., 2019, Hyperglycemia recognised in early pregnancy is phenotypically type 2 diabetes mellitus not gestational diabetes mellitus: a case control study, Journal of Maternal-fetal and Neonatal Medicine, ISSN:1476-4954, Pages:1-7

Avari P, Reddy M, Oliver N, 2019, Is it possible to constantly and accurately monitor blood sugar levels, in people with Type 1 diabetes, with a discrete device (non-invasive or invasive)?, Diabetic Medicine, ISSN:0742-3071

Oliver N, Holt RIG, 2019, The James Lind Alliance research priorities for diabetes., Diabet Med, Vol:36, Pages:267-268

Reddy M, Oliver N, 2019, Reply to Letter by Seibold regarding Monika Reddy, Narvada Jugnee, Sinthuka Anantharaja, and Nick Oliver, Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study., Diabetes Technol Ther, Vol:21, Pages:99-100

More Publications